China Regenerative Medicine International Limited (8158) Announces Delay in Circular Dispatch

Bulletin Express
Nov 21

China Regenerative Medicine International Limited (Stock Code: 8158) announced that the dispatch of a circular relating to its previously disclosed major transactions and breach of GEM Listing Rules will be delayed. The circular was initially scheduled for dispatch on or before 21 November 2025 and pertains to the Outstanding Payment Agreement, the Membership Transfer Agreements, and other related details.

The announcement specifies that additional time is needed to finalize information to be included in the circular. The company is therefore applying to the Stock Exchange for a waiver from strict compliance with the relevant GEM Listing Rules. It is currently expected that the dispatch date of the circular will be postponed to a date on or before 31 December 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10